BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 9155586)

  • 1. Chemical and immunological testing for faecal occult blood in screening subjects at risk of familial colorectal cancer.
    Hunt LM; Rooney PS; Bostock K; Robinson MH; Hardcastle JD; Armitage NC
    Gut; 1997 Jan; 40(1):110-2. PubMed ID: 9155586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Faecal occult blood testing and colonoscopy in the surveillance of subjects at high risk of colorectal neoplasia.
    Robinson MH; Kronborg O; Williams CB; Bostock K; Rooney PS; Hunt LM; Hardcastle JD
    Br J Surg; 1995 Mar; 82(3):318-20. PubMed ID: 7795994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemical and immunological testing for faecel occult blood: a comparison of two tests in symptomatic patients.
    Thomas WM; Hardcastle JD; Jackson J; Pye G
    Br J Cancer; 1992 Apr; 65(4):618-20. PubMed ID: 1562472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Population screening for colorectal cancer: comparison between guaiac and immunological faecal occult blood tests.
    Robinson MH; Marks CG; Farrands PA; Thomas WM; Hardcastle JD
    Br J Surg; 1994 Mar; 81(3):448-51. PubMed ID: 8173928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is an immunological faecal occult blood test better than Haemoccult? A cost-benefit study.
    Robinson MH; Marks CG; Farrands PA; Whynes DK; Bostock K; Hardcastle JD
    Eur J Surg Oncol; 1995 Jun; 21(3):261-4. PubMed ID: 7781793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Performance characteristics and comparison of two immunochemical and two guaiac fecal occult blood screening tests for colorectal neoplasia.
    Rozen P; Knaani J; Samuel Z
    Dig Dis Sci; 1997 Oct; 42(10):2064-71. PubMed ID: 9365136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Flexible sigmoidoscopy following a positive faecal occult blood test within a bowel screening programme may reduce the detection of neoplasia.
    Mansouri D; McMillan DC; Roxburgh CS; Moug SJ; Crighton EM; Horgan PG
    Colorectal Dis; 2013 Nov; 15(11):1375-81. PubMed ID: 23927751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of new occult blood tests for detection of colorectal neoplasia.
    St John DJ; Young GP; Alexeyeff MA; Deacon MC; Cuthbertson AM; Macrae FA; Penfold JC
    Gastroenterology; 1993 Jun; 104(6):1661-8. PubMed ID: 8500724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. One-time screening for colorectal cancer with combined fecal occult-blood testing and examination of the distal colon.
    Lieberman DA; Weiss DG;
    N Engl J Med; 2001 Aug; 345(8):555-60. PubMed ID: 11529208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Test performance of immunologic fecal occult blood testing and sigmoidoscopy compared with primary colonoscopy screening for colorectal advanced adenomas.
    Khalid-de Bakker CA; Jonkers DM; Sanduleanu S; de Bruïne AP; Meijer GA; Janssen JB; van Engeland M; Stockbrügger RW; Masclee AA
    Cancer Prev Res (Phila); 2011 Oct; 4(10):1563-71. PubMed ID: 21750209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of colorectal adenomas by a quantitative immunochemical faecal occult blood screening test depends on adenoma characteristics, development threshold used and number of tests performed.
    Rozen P; Levi Z; Hazazi R; Waked A; Vilkin A; Maoz E; Birkenfeld S; Leshno M; Niv Y
    Aliment Pharmacol Ther; 2009 Apr; 29(8):906-17. PubMed ID: 19183147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized controlled trial: Flexible sigmoidoscopy as an adjunct to faecal occult blood testing in population screening.
    Steele RJ; Carey FA; Stanners G; Lang J; Brand J; Brownlee LA; Crichton EM; Winter JW; Phull PS; Mowat C; Strachan JA; Digan AM; Fraser CG
    J Med Screen; 2020 Jun; 27(2):59-67. PubMed ID: 31690179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can quantification of faecal occult blood predetermine the need for colonoscopy in patients at risk for non-syndromic familial colorectal cancer?
    Levi Z; Rozen P; Hazazi R; Vilkin A; Waked A; Maoz E; Birkenfeld S; Niv Y
    Aliment Pharmacol Ther; 2006 Nov; 24(10):1475-81. PubMed ID: 17032281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Population based randomized study of uptake and yield of screening by flexible sigmoidoscopy compared with screening by faecal occult blood testing.
    Verne JE; Aubrey R; Love SB; Talbot IC; Northover JM
    BMJ; 1998 Jul; 317(7152):182-5. PubMed ID: 9665902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunochemical vs guaiac faecal occult blood tests in a population-based screening programme for colorectal cancer.
    Castiglione G; Zappa M; Grazzini G; Mazzotta A; Biagini M; Salvadori P; Ciatto S
    Br J Cancer; 1996 Jul; 74(1):141-4. PubMed ID: 8679448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of an immunological faecal occult blood test Fecatwin sensitive/FECA EIA with Haemoccult in population screening for colorectal cancer.
    Armitage N; Hardcastle JD; Amar SS; Balfour TW; Haynes J; James PD
    Br J Cancer; 1985 Jun; 51(6):799-804. PubMed ID: 4005139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of CT colonography, colonoscopy, sigmoidoscopy and faecal occult blood tests for the detection of advanced adenoma in an average risk population.
    Graser A; Stieber P; Nagel D; Schäfer C; Horst D; Becker CR; Nikolaou K; Lottes A; Geisbüsch S; Kramer H; Wagner AC; Diepolder H; Schirra J; Roth HJ; Seidel D; Göke B; Reiser MF; Kolligs FT
    Gut; 2009 Feb; 58(2):241-8. PubMed ID: 18852257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Faecal occult blood screening: knowledge, attitudes, and practice in four Hong Kong primary care clinics.
    Tam TK; Ng KK; Lau CM; Lai TC; Lai WY; Tsang LC
    Hong Kong Med J; 2011 Oct; 17(5):350-7. PubMed ID: 21979470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A quantitative immunochemical faecal occult blood test is more efficient for detecting significant colorectal neoplasia than a sensitive guaiac test.
    Levi Z; Hazazi R; Rozen P; Vilkin A; Waked A; Niv Y
    Aliment Pharmacol Ther; 2006 May; 23(9):1359-64. PubMed ID: 16629942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening for colorectal cancer with an immunological faecal occult blood test: 2-year follow-up.
    Robinson MH; Marks CG; Farrands PA; Bostock K; Hardcastle JD
    Br J Surg; 1996 Apr; 83(4):500-1. PubMed ID: 8665240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.